
Commentary|Videos|November 14, 2024
Dr Weiss on the Role of Breast Imaging in Breast Cancer Treatment Decision-Making
Author(s)Anna Weiss, MD
Fact checked by: Ashling Wahner , Chris Ryan
Anna Weiss, MD, discusses the significance of various imaging modalities in patients with breast cancer.
Advertisement
“We’re finding more and more that axillary lymph node dissection can be avoided in many patients, especially those who undergo neoadjuvant therapy.”
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine, discusses the significance of various imaging modalities in patients with breast cancer, as well as reasons for the declining role of axillary lymph node dissection in this disease.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
Oncology Fellows Highlights 2025 ESMO Fellowship Winners
5



































